# Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

> **NCT00034957** · PHASE2 · COMPLETED · sponsor: **Pfizer**

## Conditions studied

- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms

## Interventions

- **DRUG:** Investigational drug

## Key facts

- **NCT ID:** NCT00034957
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2002-10
- **Final completion:** 2002-10
- **Target enrollment:** — (—)
- **Last updated:** 2012-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00034957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00034957, "Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00034957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*